Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1992-8-4
|
pubmed:abstractText |
Recent data suggest that activated immune cells and their products are involved in the initiation and progression of graft-versus-host disease (GVHD). To test whether the production of endogenous interleukin-3 (IL-3), a product of activated immune cells, might be an indicator of disease activity in GVHD, we analysed sera of 61 bone marrow transplant (BMT) recipients for IL-3 levels by using an enzyme linked immunosorbent assay. Measurable levels (greater than 25 pg/ml) of endogenous IL-3 were detected in a significant subgroup (5/16 patients, 31.25%) of allograft recipients suffering from extensive chronic GVHD, but not in patients with limited chronic GVHD (n = 6) or in those without signs of chronic GVHD (n = 17). In IL-3 positive patients, IL-3 levels were not associated with pathologic conditions (such as infectious disease) other than GVHD. IL-3 levels were undetectable in disease-free phases preceding severe chronic GVHD. Lower levels of IL-3 were measured in chronic GVHD patients during extensive disease while on high dose steroid medication compared with before and/or after (p less than 0.02). IL-3 was also detected in a small group (2/17) of patients suffering from acute GVHD. IL-3 could neither be detected in syngeneic (n = 3) nor autologous (n = 7) BMT recipients nor in the vast majority (99/100) of healthy controls. Together, measurable amounts of IL-3 are produced in a significant subgroup of patients suffering from extensive chronic GVHD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0268-3369
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
331-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1617317-Adolescent,
pubmed-meshheading:1617317-Adult,
pubmed-meshheading:1617317-Biological Markers,
pubmed-meshheading:1617317-Bone Marrow Transplantation,
pubmed-meshheading:1617317-Chronic Disease,
pubmed-meshheading:1617317-Cohort Studies,
pubmed-meshheading:1617317-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:1617317-Female,
pubmed-meshheading:1617317-Graft vs Host Disease,
pubmed-meshheading:1617317-Humans,
pubmed-meshheading:1617317-Immunosuppressive Agents,
pubmed-meshheading:1617317-Incidence,
pubmed-meshheading:1617317-Interleukin-3,
pubmed-meshheading:1617317-Male,
pubmed-meshheading:1617317-Middle Aged
|
pubmed:year |
1992
|
pubmed:articleTitle |
Detection of circulating endogenous interleukin-3 in extensive chronic graft-versus-host disease.
|
pubmed:affiliation |
I. Medical Department, University of Vienna, Austria.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|